Application 212808
- Type
- ANDA
- Sponsor
- CAPLIN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | SOLUTION;INJECTION | 40MG/20ML (2MG/ML) | No | No |
| 002 | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | SOLUTION;INJECTION | 100MG/20ML (5MG/ML) | No | No |
| 003 | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | SOLUTION;INJECTION | 150MG/30ML (5MG/ML) | No | No |
| 004 | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | SOLUTION;INJECTION | 200MG/20ML (10MG/ML) | No | No |
| 005 | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | SOLUTION;INJECTION | 200MG/100ML (2MG/ML) | No | No |
| 006 | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | SOLUTION;INJECTION | 400MG/200ML (2MG/ML) | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A212808-001 | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | 40MG/20ML (2MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | |
| A212808-002 | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | 100MG/20ML (5MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | |
| A212808-003 | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | 150MG/30ML (5MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | |
| A212808-004 | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | 200MG/20ML (10MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | |
| A212808-005 | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | 200MG/100ML (2MG/ML) | SOLUTION / INJECTION | AP | 2024-05-23 | |
| A212808-006 | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | 400MG/200ML (2MG/ML) | SOLUTION / INJECTION | AP | 2024-05-23 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A212808-001 | AP |
| A212808-002 | AP |
| A212808-003 | AP |
| A212808-004 | AP |
| A212808-005 | AP |
| A212808-006 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A212808-001 | ROPIVACAINE HYDROCHLORIDE | 40MG/20ML (2MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212808-002 | ROPIVACAINE HYDROCHLORIDE | 100MG/20ML (5MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212808-003 | ROPIVACAINE HYDROCHLORIDE | 150MG/30ML (5MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212808-004 | ROPIVACAINE HYDROCHLORIDE | 200MG/20ML (10MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212808-005 | ROPIVACAINE HYDROCHLORIDE | 200MG/100ML (2MG/ML) | SOLUTION / INJECTION | AP | 2024-05-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212808-006 | ROPIVACAINE HYDROCHLORIDE | 400MG/200ML (2MG/ML) | SOLUTION / INJECTION | AP | 2024-05-23 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212808-001 | ROPIVACAINE HYDROCHLORIDE | 40MG/20ML (2MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212808-002 | ROPIVACAINE HYDROCHLORIDE | 100MG/20ML (5MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212808-003 | ROPIVACAINE HYDROCHLORIDE | 150MG/30ML (5MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212808-004 | ROPIVACAINE HYDROCHLORIDE | 200MG/20ML (10MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212808-005 | ROPIVACAINE HYDROCHLORIDE | 200MG/100ML (2MG/ML) | SOLUTION / INJECTION | AP | 2024-05-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212808-006 | ROPIVACAINE HYDROCHLORIDE | 400MG/200ML (2MG/ML) | SOLUTION / INJECTION | AP | 2024-05-23 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212808-001 | ROPIVACAINE HYDROCHLORIDE | 40MG/20ML (2MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212808-002 | ROPIVACAINE HYDROCHLORIDE | 100MG/20ML (5MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212808-003 | ROPIVACAINE HYDROCHLORIDE | 150MG/30ML (5MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212808-004 | ROPIVACAINE HYDROCHLORIDE | 200MG/20ML (10MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212808-005 | ROPIVACAINE HYDROCHLORIDE | 200MG/100ML (2MG/ML) | SOLUTION / INJECTION | AP | 2024-05-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212808-006 | ROPIVACAINE HYDROCHLORIDE | 400MG/200ML (2MG/ML) | SOLUTION / INJECTION | AP | 2024-05-23 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212808-001 | ROPIVACAINE HYDROCHLORIDE | 40MG/20ML (2MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212808-002 | ROPIVACAINE HYDROCHLORIDE | 100MG/20ML (5MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212808-003 | ROPIVACAINE HYDROCHLORIDE | 150MG/30ML (5MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212808-004 | ROPIVACAINE HYDROCHLORIDE | 200MG/20ML (10MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212808-005 | ROPIVACAINE HYDROCHLORIDE | 200MG/100ML (2MG/ML) | SOLUTION / INJECTION | AP | 2024-05-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212808-006 | ROPIVACAINE HYDROCHLORIDE | 400MG/200ML (2MG/ML) | SOLUTION / INJECTION | AP | 2024-05-23 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212808-001 | ROPIVACAINE HYDROCHLORIDE | 40MG/20ML (2MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212808-002 | ROPIVACAINE HYDROCHLORIDE | 100MG/20ML (5MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212808-003 | ROPIVACAINE HYDROCHLORIDE | 150MG/30ML (5MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212808-004 | ROPIVACAINE HYDROCHLORIDE | 200MG/20ML (10MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212808-005 | ROPIVACAINE HYDROCHLORIDE | 200MG/100ML (2MG/ML) | SOLUTION / INJECTION | AP | 2024-05-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212808-006 | ROPIVACAINE HYDROCHLORIDE | 400MG/200ML (2MG/ML) | SOLUTION / INJECTION | AP | 2024-05-23 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212808-001 | ROPIVACAINE HYDROCHLORIDE | 40MG/20ML (2MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212808-002 | ROPIVACAINE HYDROCHLORIDE | 100MG/20ML (5MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212808-003 | ROPIVACAINE HYDROCHLORIDE | 150MG/30ML (5MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212808-004 | ROPIVACAINE HYDROCHLORIDE | 200MG/20ML (10MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212808-005 | ROPIVACAINE HYDROCHLORIDE | 200MG/100ML (2MG/ML) | SOLUTION / INJECTION | AP | 2024-05-23 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212808-006 | ROPIVACAINE HYDROCHLORIDE | 400MG/200ML (2MG/ML) | SOLUTION / INJECTION | AP | 2024-05-23 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212808-001 | ROPIVACAINE HYDROCHLORIDE | 40MG/20ML (2MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212808-002 | ROPIVACAINE HYDROCHLORIDE | 100MG/20ML (5MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212808-003 | ROPIVACAINE HYDROCHLORIDE | 150MG/30ML (5MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212808-004 | ROPIVACAINE HYDROCHLORIDE | 200MG/20ML (10MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 2680178bc6a6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A212808-001 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212808-002 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212808-003 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212808-004 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212808-005 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212808-006 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212808-001 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212808-002 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212808-003 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212808-004 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212808-005 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212808-006 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A212808-001 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A212808-002 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A212808-003 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A212808-004 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A212808-005 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A212808-006 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212808-001 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212808-002 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212808-003 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212808-004 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212808-005 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212808-006 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212808-001 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212808-002 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212808-003 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212808-004 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212808-005 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212808-006 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212808-001 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212808-002 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212808-003 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212808-004 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212808-005 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212808-006 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212808-001 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212808-002 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212808-003 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212808-004 | AP | 1 | 2680178bc6a6… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | Armas Pharmaceuticals Inc. | 3849f5ce-d077-4318-935d-294be6948142 | 2026-05-20 | Warnings, Adverse reactions | 212808 ANDA212808 |
| ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | SOLA Pharmaceuticals, LLC | 5b3c642b-ab31-45fd-ac0b-b9f6e6cfe3a9 | 2025-12-08 | Warnings, Adverse reactions | 212808 ANDA212808 |
| Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | FRESENIUS KABI USA, LLC | da4a7675-97bf-4d2a-9fdc-c1b4b2999126 | 2025-06-30 | Warnings, Adverse reactions | 212808 ANDA212808 |
| Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | Caplin Steriles Limited | a9010ea8-0923-44e4-a7c7-7d65d37d06db | 2025-06-24 | Warnings, Adverse reactions | 212808 ANDA212808 65145-110 65145-109 65145-107 65145-108 |
| Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | Civica, Inc. | 1fb8e90a-4141-4707-8be6-31f2da5c8fd5 | 2024-11-07 | Warnings, Adverse reactions | 212808 ANDA212808 72572-707 |
| Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | NorthStar Rx LLC | 61896fe6-4a5a-4e0f-bfc2-44265bc1f2c1 | 2024-01-01 | Warnings, Adverse reactions | 212808 ANDA212808 |
| ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | Baxter Healthcare Corporation | 781d4b7f-7556-4695-8d48-7772d7a0d8e9 | 2023-06-28 | Warnings, Adverse reactions | 212808 ANDA212808 43066-023 43066-015 43066-019 43066-027 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 43066-015 | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | Baxter Healthcare Corporation | ANDA | Current |
| 43066-015 | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | Baxter Healthcare Corporation | ANDA | Current |
| 43066-015 | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | Baxter Healthcare Corporation | ANDA | Current |
| 43066-015 | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | Baxter Healthcare Corporation | ANDA | Current |
| 43066-019 | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | Baxter Healthcare Corporation | ANDA | Current |
| 43066-019 | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | Baxter Healthcare Corporation | ANDA | Current |
| 43066-019 | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | Baxter Healthcare Corporation | ANDA | Current |
| 43066-019 | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | Baxter Healthcare Corporation | ANDA | Current |
| 43066-023 | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | Baxter Healthcare Corporation | ANDA | Current |
| 43066-023 | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | Baxter Healthcare Corporation | ANDA | Current |
| 43066-023 | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | Baxter Healthcare Corporation | ANDA | Current |
| 43066-023 | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | Baxter Healthcare Corporation | ANDA | Current |
| 43066-027 | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | Baxter Healthcare Corporation | ANDA | Current |
| 43066-027 | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | Baxter Healthcare Corporation | ANDA | Current |
| 43066-027 | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | Baxter Healthcare Corporation | ANDA | Current |
| 43066-027 | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | Baxter Healthcare Corporation | ANDA | Current |
| 65145-107 | Ropivacaine Hydrochloride | Ropivacaine Hydrochloride | Caplin Steriles Limited | ANDA | Current |
| 65145-108 | Ropivacaine Hydrochloride | Ropivacaine Hydrochloride | Caplin Steriles Limited | ANDA | Current |
| 65145-109 | Ropivacaine Hydrochloride | Ropivacaine Hydrochloride | Caplin Steriles Limited | ANDA | Current |
| 65145-110 | Ropivacaine Hydrochloride | Ropivacaine Hydrochloride | Caplin Steriles Limited | ANDA | Current |
| 72572-707 | Ropivacaine Hydrochloride | Ropivacaine Hydrochloride | Civica, Inc. | ANDA | Current |